Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials • Semiconductors, Circuits & Optics
5 pending office actions • 4 clients • 5 examiners • 5 art units • 0 of 5 (0%) have an AI response strategy ready
COSUD INTELLECTUAL PROPERTY SOLUTIONS, P.C. operates in the Biotechnology & Pharmaceuticals technology area, with 1288 career applications. The firm currently manages 5 pending office actions, reflecting their active role in the patent process. This career total of 1288 applications establishes their experience in Biotechnology & Pharmaceuticals. The 5 pending office actions are a current measure of their prosecution work.
The firm maintains a resolved allowance rate of 79.39 percent, a metric calculated from their 1288 career applications. This 79.39 percent rate indicates the firm's success in achieving patent grants. Prosecution requires an average of 3.01 office actions per allowance. For practitioners, this 3.01 average provides a clear expectation for the number of examiner interactions. The 5 pending office actions are managed alongside this 79.39 percent allowance rate and 3.01 office action average. These figures collectively describe the firm's historical performance and current engagement in their primary technology area.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (40%) |
| Multi-statute (no §101) | 3 (60%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HOLLINGTON, JERMELE M | 1 | 86.3% | -15.4% |
| PIPIC, ALMA | 1 | 54.6% | +54.7% |
| WITTENBERG, STEFANIE S | 1 | 54.4% | +17.8% |
| NGUYEN, JOHN P | 1 | 43.9% | +41.8% |
| ABDALHAMEED, MANAHIL MIRGHANI ALI | 1 | 50.3% | +38.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18888510 | ELECTRICAL IMPEDANCE SPTROSCOPY FOR NON-DESTRUCTIVE, REAL-TIME, TRACKING OF RELATIVE WATER CONTENT AND STRESS RESPONSE IN PLANTS | HOLLINGTON, JERMELE M | — |
| 18775053 | Diagnosis and Treatment of Metabolic Syndrome with Magnesium Compositions | PIPIC, ALMA | — |
| 18282837 | Dynamic Glass Element Using Reversible Metal Electrodeposition Electrolytes with Tunable PH with High Opacity and Excellent Resting Stability and Electrolytes Useful Therefore | WITTENBERG, STEFANIE S | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18775053 | Diagnosis and Treatment of Metabolic Syndrome with Magnesium Compositions | PIPIC, ALMA | — |
| 18282837 | Dynamic Glass Element Using Reversible Metal Electrodeposition Electrolytes with Tunable PH with High Opacity and Excellent Resting Stability and Electrolytes Useful Therefore | WITTENBERG, STEFANIE S | — |
| 18073852 | DRUG THERAPY TO INHIBIT CHEMOTHERAPY-INDUCED ADVERSE EFFECTS AND RELATED PHARMACEUTICAL COMPOSITIONS, DIAGNOSTICS, SCREENING TECHNIQUES AND KITS | NGUYEN, JOHN P | — |
| 17801486 | TREATMENT FOR CHEMOBRAIN | ABDALHAMEED, MANAHIL MIRGHANI ALI | — |
| Client (Assignee) | Pending OAs |
|---|---|
| Yale University | 2 |
| UNM RAINFOREST INNOVATIONS | 1 |
| U.S. Department of Veterans Affairs | 1 |
| University of Nevada | 1 |
| Art Unit | Apps |
|---|---|
| 2858 | 1 |
| 1617 | 1 |
| 1795 | 1 |
| 1619 | 1 |
| 1622 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 18888510 | ELECTRICAL IMPEDANCE SPTROSCOPY FOR NON-DESTRUCTIVE, REAL-TIME, TRACKING OF RELATIVE WATER CONTENT AND STRESS RESPONSE IN PLANTS | UNM RAINFOREST INNOVATIONS | HOLLINGTON, JERMELE M | 2858 | §102§103§112 | Non-Final OA | — | Pending | Sep 18, 2024 |
| 18775053 | Diagnosis and Treatment of Metabolic Syndrome with Magnesium Compositions | The United States Department of Veterans Affairs | PIPIC, ALMA | 1617 | §102§103§112 | Non-Final OA | — | Pending | Jul 17, 2024 |
| 18282837 | Dynamic Glass Element Using Reversible Metal Electrodeposition Electrolytes with Tunable PH with High Opacity and Excellent Resting Stability and Electrolytes Useful Therefore | The Board Of Regents Of The Nevada System Of Higher Education, On Behalf Of The University Of Nevada | WITTENBERG, STEFANIE S | 1795 | §103§112 | Non-Final OA | — | Pending | Sep 19, 2023 |
| 18073852 | DRUG THERAPY TO INHIBIT CHEMOTHERAPY-INDUCED ADVERSE EFFECTS AND RELATED PHARMACEUTICAL COMPOSITIONS, DIAGNOSTICS, SCREENING TECHNIQUES AND KITS | Yale University | NGUYEN, JOHN P | 1619 | §103 | Non-Final OA | — | Pending | Dec 02, 2022 |
| 17801486 | TREATMENT FOR CHEMOBRAIN | Yale University | ABDALHAMEED, MANAHIL MIRGHANI ALI | 1622 | §103 | Final Rejection | — | Pending | Aug 22, 2022 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial